CHUT (Telemedicine Department with formal links to Institut Européen de Télémédecine, and Gerontechnology La Grave Laboratory)

CHU Toulouse, Toulouse University Hospital, is the regional hospital of Midi Pyrénées. Midi Pyrénées is the widest French metropolitan region with 45 348 km2(the size of Denmark, bigger than Belgiumor Switzerland). Its role made it the first regional employer before Airbus. Having to attend such a big region it is no doubt that it had to be at the frontline of Telemedicine and eHealth. It was the place of birth of both the European Institute of Telemedicine university institute and the GIP RTeS@ Midi Pyrénées regionwide Telemedicine network, now GCS TélésantéMidi Pyrénées telemedicine activity management body under the authority of ARS Midi Pyrénées regional health agency. CHU Toulouse is a founder member of GCS Télésanté. Since March 2010, CHU Toulouse proved once again its commitment to access to care through innovative technologies with the creation of the Centre e-Santé Foundation (a member of GCS Télésanté). Sud-Ouest of France is known for its excellent quality of life and over-average longevity. CHU Toulouse has some of the leading teams in Geriatric medicine and Gerontechnology research and development gathered under the Gerontopôle. The La Grave Gerontechnology Lab is working since 2003 on the development of tailored technologies for the old and handicapped people, with a special emphasis on the inclusion of those with cognitive impairment.

Role in DOMEO

CHUT provides specification, research and development on special computer interactions for cognitively impaired patients (in collaboration with TAS), ethical reflection, discussion with NIMR and TUW on needs evaluation, lab testing of the provided robots at debugging stage (with Robosoft), deployment of the full telecom infrastructure and robots tests with that infrastructure.We will organize field testing at user’s premises, in our French region, when the different parts of Domeo will have acquired a sufficient robustness validated by the medical and care partners according to the results provided. We are expecting telemedicine service model field tests for the end of the project.